Results 151 to 160 of about 14,668 (165)

Daratumumab for the Treatment of Multiple Myeloma [PDF]

open access: yesFrontiers in Immunology, 2018
This mini-review will summarize the present state of development of the CD38 antibody daratumumab for the treatment of multiple ...
Torben Plesner, Jakub Krejcik
exaly   +2 more sources

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma [PDF]

open access: yesNew England Journal of Medicine, 2016
BACKGROUND Daratumumab, a human IgG kappa monoclonal antibody that targets CD38, induces direct and indirect antimyeloma activity and has shown substantial efficacy as monotherapy in heavily pretreated patients with multiple myeloma, as well as in ...
Tomer M Mark   +2 more
exaly   +2 more sources

Interference of Daratumumab in Monitoring Multiple Myeloma Patients Using Serum Immunofixation Electrophoresis Can Be Abrogated Using the Daratumumab IFE Reflex Assay (DIRA)

open access: yesClinical Chemistry and Laboratory Medicine, 2016
Daratumumab is a fully human anti-CD38 IgG1-κ monoclonal antibody (mAb) currently being evaluated in several Phase 2 and 3 clinical studies for the treatment of multiple myeloma (MM).
Hans Jacobs   +2 more
exaly   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Targeting CD38 With Daratumumab in Refractory Systemic Lupus Erythematosus

New England Journal of Medicine, 2020
Andreas Radbruch   +2 more
exaly  

Daratumumab for Delayed Red-Cell Engraftment After Allogeneic Transplantation

New England Journal of Medicine, 2018
Jean M Connors   +2 more
exaly  

Daratumumab Plus Lenalidomide and Dexamethasone for Untreated Myeloma

New England Journal of Medicine, 2019
Shaji K Kumar   +2 more
exaly  

F(Ab′)2 Fragments to Overcome Daratumumab Interference in Transfusion Tests

New England Journal of Medicine, 2018
Thomas Thiele, Kathleen Selleng
exaly  

Targeting CD38 With Daratumumab Monotherapy in Multiple Myeloma

New England Journal of Medicine, 2015
Jacob P Laubach   +2 more
exaly  

Home - About - Disclaimer - Privacy